ReviewMedical oncology (Northwood, London, England)2025
Targeted drug delivery in cervical carcinoma: the role of gold nanoparticles in enhancing treatment efficacy.
Review in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review.International journal of molecular sciences · 2026Pooled it
- Advancements in nanobiosensors for early cancer detection, challenges, treatment, and future prospects: a comprehensive review.Discover nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the fourth most common cancer affecting women globally, cervical cancer presents a significant health challenge. Nanotechnology offers a promising new frontier for treatment, with gold nanoparticles (AuNPs) emerging as a powerful tool for enhancing therapeutic effectiveness.This review focuses on the synthesis of AuNPs and their strategic application in targeted drug delivery systems to combat cervical cancer. Gold nanoparticles are exceptionally well suited for this role due to a unique combination of properties, including their small size, high surface-area-to-volume ratio, excellent stability, and biocompatibility. These traits make them ideal vehicles for medical use.Beyond targeted drug delivery, AuNPs can also act as radiosensitizers, increasing the susceptibility of cancer cells to radiation. This synergy has the potential to make radiation therapy more precise and effective, highlighting the multifaceted role of gold nanoparticles in developing more advanced and targeted treatments for cervical cancer.
Indexed as
Identifiers
41107670What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.